Lexaria Bioscience to execute 1-for-15 reverse stock split Aug. 3 - LEXX News | RalliesLexaria Bioscience to execute 1-for-15 reverse stock split Aug. 3
L
LEXX• Reverse stock split effective Aug. 3
- Lexaria Bioscience will execute a 1-for-15 reverse stock split effective 12:01 a.m. EST on Aug. 3, 2026.
- The move targets Nasdaq’s $1 minimum bid price requirement, aiming to regain compliance and support continued listing.
- Issued shares will consolidate to 1,652,518 from 24,787,446, with fractional shares rounded up to whole shares.
- Authorized shares will drop to 14,666,667 from 220,000,000; par value will remain unchanged, leaving ownership percentages unchanged.
- Post-split shares will trade under LEXX with new CUSIP 52886N604; options and warrants will be adjusted.
